[1]
“Reply to comment by Carratù P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial”, Swiss Med Wkly, vol. 149, no. 3940, p. w20133, Sep. 2019, doi: 10.4414/smw.2019.20133.